The treatment combines a new drug, inavolisib, with two older breast cancer drugs, fulvestrant (Faslodex ®) and palbociclib (Ibrance ®) . Inavolisib, which targets PIK3CA mutations, appears to be a ...

LBC, also known as invasive lobular carcinoma, forms in the lobules, which are the small round sacs that make breast milk.

“We know from research that breast cancer outcomes get worse with weight gain that is more than 5% of a person’s total body ...

As a parent, learn how to navigate sensitive, open conversations with children and teens about your cancer diagnosis.